These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Platelets contribute to the reduction of liver fibrosis in mice. Watanabe M; Murata S; Hashimoto I; Nakano Y; Ikeda O; Aoyagi Y; Matsuo R; Fukunaga K; Yasue H; Ohkohchi N J Gastroenterol Hepatol; 2009 Jan; 24(1):78-89. PubMed ID: 18624898 [TBL] [Abstract][Full Text] [Related]
9. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Higashiyama R; Moro T; Nakao S; Mikami K; Fukumitsu H; Ueda Y; Ikeda K; Adachi E; Bou-Gharios G; Okazaki I; Inagaki Y Gastroenterology; 2009 Oct; 137(4):1459-66.e1. PubMed ID: 19596008 [TBL] [Abstract][Full Text] [Related]
10. Antifibrotic effect through the regulation of transcription factor using ring type-Sp1 decoy oligodeoxynucleotide in carbon tetrachloride-induced liver fibrosis. Park JH; Jo JH; Kim KH; Kim SJ; Lee WR; Park KK; Park JB J Gene Med; 2009 Sep; 11(9):824-33. PubMed ID: 19554625 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride-induced chronic liver injury. Hagiwara S; Otsuka T; Yamazaki Y; Kosone T; Sohara N; Ichikawa T; Sato K; Kakizaki S; Takagi H; Mori M Liver Int; 2008 Jan; 28(1):126-31. PubMed ID: 17976157 [TBL] [Abstract][Full Text] [Related]
12. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Popov Y; Schuppan D Hepatology; 2009 Oct; 50(4):1294-306. PubMed ID: 19711424 [TBL] [Abstract][Full Text] [Related]
13. Experimental models of hepatic fibrosis: a review. Tsukamoto H; Matsuoka M; French SW Semin Liver Dis; 1990 Feb; 10(1):56-65. PubMed ID: 2110685 [TBL] [Abstract][Full Text] [Related]
14. Effect of cholinergic denervation on hepatic fibrosis induced by carbon tetrachloride in rats. Lam HB; Yeh CH; Cheng KC; Hsu CT; Cheng JT Neurosci Lett; 2008 Jun; 438(1):90-5. PubMed ID: 18472332 [TBL] [Abstract][Full Text] [Related]
15. Reevaluation of experimental model of hepatic fibrosis induced by hepatotoxic drugs: an easy, applicable, and reproducible model. Jang JH; Kang KJ; Kim YH; Kang YN; Lee IS Transplant Proc; 2008 Oct; 40(8):2700-3. PubMed ID: 18929839 [TBL] [Abstract][Full Text] [Related]
16. Loss of Sept4 exacerbates liver fibrosis through the dysregulation of hepatic stellate cells. Iwaisako K; Hatano E; Taura K; Nakajima A; Tada M; Seo S; Tamaki N; Sato F; Ikai I; Uemoto S; Kinoshita M J Hepatol; 2008 Nov; 49(5):768-78. PubMed ID: 18804890 [TBL] [Abstract][Full Text] [Related]
17. Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosis. Loebermann M; Sombetzki M; Langner C; Fuchsbichler A; Gumhold J; Silbert D; Riebold D; Holtfreter M; Fickert P; Nizze H; Trauner M; Reisinger EC Trop Med Int Health; 2009 Nov; 14(11):1418-25. PubMed ID: 19747186 [TBL] [Abstract][Full Text] [Related]
18. Relationship between anti-fibrotic effect of Panax notoginseng saponins and serum cytokines in rat hepatic fibrosis. Peng XD; Dai LL; Huang CQ; He CM; Yang B; Chen LJ Biochem Biophys Res Commun; 2009 Oct; 388(1):31-4. PubMed ID: 19632202 [TBL] [Abstract][Full Text] [Related]
19. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice. Xu W; Wang LW; Shi JZ; Gong ZJ Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172 [TBL] [Abstract][Full Text] [Related]
20. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model. Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]